EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS091-24358 
Organism
Homo sapiens 
Tissue/cell
HepG2 
Coordinate
chr19:46910180-46912450 
TF binding sites/motifs
Number: 35             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr19:46912346-46912364GGAAGGAAGGAAGGAAAG+10.53
EWSR1-FLI1MA0149.1chr19:46912342-46912360GGAAGGAAGGAAGGAAGG+10.83
EWSR1-FLI1MA0149.1chr19:46912319-46912337GGGAGGGAGGAAGAAAGA+6.06
EWSR1-FLI1MA0149.1chr19:46912315-46912333GGGAGGGAGGGAGGAAGA+6.36
EWSR1-FLI1MA0149.1chr19:46912354-46912372GGAAGGAAAGGAGGGAGG+6.72
EWSR1-FLI1MA0149.1chr19:46912334-46912352AGAAAGAGGGAAGGAAGG+6.94
EWSR1-FLI1MA0149.1chr19:46912350-46912368GGAAGGAAGGAAAGGAGG+7.79
EWSR1-FLI1MA0149.1chr19:46912338-46912356AGAGGGAAGGAAGGAAGG+7.85
Foxd3MA0041.1chr19:46910204-46910216AAACAAACAAAC-6.32
Foxd3MA0041.1chr19:46910208-46910220AAACAAACAAAC-6.32
Foxd3MA0041.1chr19:46910212-46910224AAACAAACAAAC-6.32
Foxd3MA0041.1chr19:46910216-46910228AAACAAACAAAC-6.32
Foxd3MA0041.1chr19:46910220-46910232AAACAAACAAAC-6.32
IRF1MA0050.2chr19:46912267-46912288AGAGAGAAAGAGAAAGGAAAG-6.8
ZNF263MA0528.1chr19:46912321-46912342GAGGGAGGAAGAAAGAAAGAG+6.06
ZNF263MA0528.1chr19:46912390-46912411GGGAGAGGGAGAGGGGAGGGA+6.18
ZNF263MA0528.1chr19:46912309-46912330GAGAGAGGGAGGGAGGGAGGA+6.19
ZNF263MA0528.1chr19:46912335-46912356GAAAGAGGGAAGGAAGGAAGG+6.22
ZNF263MA0528.1chr19:46912339-46912360GAGGGAAGGAAGGAAGGAAGG+6.24
ZNF263MA0528.1chr19:46912405-46912426GAGGGAGAGAGGGAGAGGGGA+6.24
ZNF263MA0528.1chr19:46912347-46912368GAAGGAAGGAAGGAAAGGAGG+6.28
ZNF263MA0528.1chr19:46912343-46912364GAAGGAAGGAAGGAAGGAAAG+6.48
ZNF263MA0528.1chr19:46912379-46912400GGGGAAGGGGAGGGAGAGGGA+6.49
ZNF263MA0528.1chr19:46912388-46912409GAGGGAGAGGGAGAGGGGAGG+6.5
ZNF263MA0528.1chr19:46912360-46912381AAAGGAGGGAGGGTGGGAGGG+6.64
ZNF263MA0528.1chr19:46912364-46912385GAGGGAGGGTGGGAGGGGGAA+6.66
ZNF263MA0528.1chr19:46912375-46912396GGAGGGGGAAGGGGAGGGAGA+6.75
ZNF263MA0528.1chr19:46912324-46912345GGAGGAAGAAAGAAAGAGGGA+6.7
ZNF263MA0528.1chr19:46912313-46912334GAGGGAGGGAGGGAGGAAGAA+6.8
ZNF263MA0528.1chr19:46912401-46912422AGGGGAGGGAGAGAGGGAGAG+7.02
ZNF263MA0528.1chr19:46912351-46912372GAAGGAAGGAAAGGAGGGAGG+7.18
ZNF263MA0528.1chr19:46912378-46912399GGGGGAAGGGGAGGGAGAGGG+7.39
ZNF263MA0528.1chr19:46912384-46912405AGGGGAGGGAGAGGGAGAGGG+7.45
ZNF740MA0753.2chr19:46911643-46911656CCCCCCCCCCCCC+6.03
ZNF740MA0753.2chr19:46911645-46911658CCCCCCCCCCCAT+6.07
Number of super-enhancer constituents: 3             
IDCoordinateTissue/cell
SE_29984chr19:46910945-46913106Fetal_Muscle
SE_46970chr19:46910193-46910569Ovary
SE_46970chr19:46911051-46912274Ovary
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr194691076546910889
chr194691180046912200
chr194691108346912310
Number: 1             
IDChromosomeStartEnd
GH19I046407chr194691041146913124
Enhancer Sequence
TGACAGAGCG AGACTCTGTC ACAAAAACAA ACAAACAAAC AAACAAACAA ACAATGAGGA 60
GCAGCTGGAC TGGTCCAGAT GAAGGCTGAT TCAGAGACCA ATCTCTGGTT TCCTGGGCTT 120
CCTCTTGGAA ACCTTCGTGC ATTTGAAACC ACACCCCAGA GGCATCAAGG GACTGACTGG 180
CCCTGCAGGT GCTGTTTGAA GGCCCCTGCG CTGAAATATA ATAGCGAACA CTCTGTTCTG 240
TCTCAGTTAC TAGAGGGCTC CCCTACCTGT GGGGCCTCCC TGAATGCTCA CGGTGGGGAT 300
GCTGGGAACA GTTCAGAAAA GGTTGTGTTC ACTCGGGGGG CAACAAATTT TGACTCAGTG 360
GGGGATAGAC TTGCCCAAAG CCTCAGGGCC ACCCAGAAAG GCTATGCAAA TAAGACCCAG 420
GGATGGCCGG GTATACAAGT AAGACTGGGG GGGCTGAGGC ACGAGAATTG CTTGAACCCG 480
GGAGGCAGAG GTTGCAGTGA GTTGAGATCC CACCACTGCA CTCCAGCCTG GTTGACAGAG 540
ACTCTGCCTA AAAACAAAAA CAAAAACAAA CAAAAAAACC CAGGGAGACG GTGTGAAACT 600
GTTTCTTTTT TCTTTTTTGA GACAGGGTTT TGCTTGTTGC CCAGGTTGGA GTACAATAGC 660
GCAATCTCAG CTCGCCGCAA CCTCCTGGGT TCAACTGATC CTCCTCCTAC CTCAGCCTCC 720
CGAGTAGCTG GGATTACAGG CATGCACCAT CATGCCCAGC TAATTTTTTG TATTTTTAGT 780
ACAGATGGGG TTTCACCATG TTGGCCAGGC TGGTCTCGAA CTCCTGACTT CAGGTGATCC 840
ACCCACCTCG GCCTCCCAAA ATGCTGGGAT TACAGGCGTG AGCCACCGCG CCCGGCTGTG 900
AAACTTTCTG CAAGCATCTG TGTGTCTGTG ACTGCCTGGC TTTTGAGTTT GTGTGATAAC 960
ATGTGAGTGT GTCCATCTGG CTGAGGGAAT CAAAGTGTCC AACGGCATCT AGCAGTGTGT 1020
GACGGGTCCT GAGTGGGTGA ACACGTTGAC ATTTCCAAGT ATGTCAGTGT TTGTATGAAT 1080
GGGTCTGTGA ATGTGTGGGG GTTGGCTTCC CGGAGCACAG TGGGTCTGTG CGCCTCTGTG 1140
AGTACACGTG TGTGTACTAC ATGTGTGTGT CCGTGTCTGT GTCTATGTAT GGGCAGATTA 1200
ATCATAATTT CTGTTGGTGA ATGTGGGTCT GCCAGTGGTG CCTGAGTGTA CATGTGTCTG 1260
TGGTATGTGC TGTGCCTGCG TGCCTGGATC CGAGTGTGCA TGTGTCTATG TGTGTGTCCA 1320
CACGTGTATG GCAGTGAGAG AGACTGACCC AGTGTTGCCT GATGTCTGTG AAATCCACGC 1380
AGCTCCTCGT TTAACTCCAT CTTGCCACTT GTTTGGGGTC CACACCACTT TCCTTCTCAT 1440
GGGCCCCTGA TGTTCCCCCG AGACCCCCCC CCCCCCATAG CTCTGGGCGC TGCAGGGAGG 1500
AGGAGCAGAG AGACTCGCTC TGAGCCTTCA TTTCCTGCAT TCATGCCGTC GGCTCCTCCA 1560
GTCTCCGAAT CCCTCCAAAC ATCTGTCTCT GCTGTTCCTT TTTACCTTCC AGCTCCTCAG 1620
GCAGGCCAGG TCCCCATGGT CACGAGACCT CTGCCCTCCG AAGTGGGCAG CGACAAAGGA 1680
CAGCCTCCCT CCCCACCAAC CAGAACCTTC CCACCCAGCC TGTCTTCCTC CGCGCACCTG 1740
CAAAGCCTCC CCTCCAGGTG AGGTCCACAG CTTGTATTTC TTCCAAACCT CCCAGGGCCT 1800
CGTTCTTGCT GTGAGCCGTG GACTACACGG CCAAGTATCC ACCAGCATGC ACAAAGCGGC 1860
TCTAGCAAGG CCATGCGGCG CGCCAGGCAG CAAGCAGCAC CAGCAGTAAC CACTCCACTC 1920
AGAAAAGAGC AGGGGTGGGG CGCGGTGGCT CACTCCCATA GTCCCAGAGC TGAGGCCAGA 1980
GGATCGCTTG ATCCCAAGAG TGCAAGTGAG CCGTGATTGC AACACCACAC TCCAGCCTGG 2040
GTGACAGAGC CAGACCCTGT CTTGAAAGAA AGAAAAGAGT AAAGAAAAGA GAGAAAGAGA 2100
AAGGAAAGAA AGCAAGAGAG AGAGAGAAAG AGAGAGGGAG GGAGGGAGGA AGAAAGAAAG 2160
AGGGAAGGAA GGAAGGAAGG AAAGGAGGGA GGGTGGGAGG GGGAAGGGGA GGGAGAGGGA 2220
GAGGGGAGGG AGAGAGGGAG AGGGGAGGGG AGTGGAGGGA GAGAGGGAGA 2270